Dr. George Fareed, Imperial Valley frontline doctor fighting against the COVID-19 pandemic locally, has been fielding phone calls from across the nation helping those afflicted but unable to get early treatment from their medical establishments.
“I’m really busy, but I’m willing to help anyone,” Fareed said.
The doctor reached out to The Desert Review suggesting publication of the Protocol he and Dr. Brian Tyson have refined for their local patients that has been so successful. Fareed also included in his material what Dr. Zelenko, a pioneer in repurposing medicines for the virus has developed as a prophylaxis, a preventative subscription.
Also included in the material submitted, is a follow up to Dr. Fareed’s U.S. Senate hearing, “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution” held November 19 in the Capitol.
Senator Josh Hawley submitted questions to Dr. Fareed to clarify his testimony for the record. Here is the correspondence between the Senator and Fareed on December 10:
Sen. Hawley: In your testimony, you say that timing is everything when it comes to treatment and that the best time for outpatient treatment to prevent hospitalization comes when “the virus is in a period of maximum replication in the upper respiratory tract.” Can you explain what this would mean for a patient? Would this be five days after exposure, or ten days? Or is it based on symptoms?
Dr. Fareed: The earlier the treatment can be started after the start of the infection, the better and more rapid the recovery (as well as the reduction in the risk of spread/contagious period). This would mean that the patient should optimally start the treatment in the first 4 days of the infection and within five days of exposure. It usually is based on symptoms which start within 1-4 days of viral entry into the upper respiratory system. Even starting the multi-faceted treatment later (7-10 days after infection) is also very worthwhile if severe pneumonia necessitating hospitalization has not yet set in.
Sen. Hawley: In your experience, are patients typically coming in to get treated at this point in their illness? And if not, what do you think we need to do to encourage high-risk individuals to seek outpatient treatment and care?
Dr. Fareed: More patients are coming in to get treated or contacting me from afar for treatment when they can’t receive the treatment in their local communities. Sadly, many infected people and primary care doctors and doctors in ERs follow the NIH and Dr. Fauci stipulations with no effective treatments offered. We need to have the NIH/FDA/CDC formally acknowledge the importance of early treatment with moderately acting, safe anti-virals so readily available. When (if ever) that happens, everything would improve dramatically. Thank you, Senator Hawley, for all your efforts and for allowing me to respond to these excellent questions.
The following is the protocol Drs. Fareed and Tyson have jointly developed as most effective for their COVID-19 patients:
(Azithromycin tab one per day or doxycycline cap twice a day)
Ivermectin 12 mg on day 1 only
Aspirin 325 mg
Days 2-5
HCQ tab 3 times a day
Zinc sulfate 3 times a day
(Azithromycin tab daily or doxycycline cap twice a day)
Aspirin 325 mg daily
Ivermectin 12 mg on day 3 if symptoms warrant
Prednisone 60 mg daily x 5-7 days or
Dexamethasone 4 mg bid if wheezing /SOB
Budesonide 0.5-1mg/2ml vía nebulizer bid
Vitamin D3 5000 iu daily
Pepcid 20 mg daily
Continue daily Aspirin 325 mg
Over the counter prevention:
Elemental Zinc 25 mg once a day
Vitamin D 4000 iu once a day
Vitamin C 1000 mg once a day
Quercetin 500 mg once a day
If Quercetin is unavailable, then use Epigallocatechin-gallate (EGCG) 400mg once a day
Dr. Fareed also included Dr. Zelenko’s (Twitter: @zev_dr) COVID-19 Prophylaxis Protocol:
Prophylaxis is an action taken to prevent or protect against a specified disease. Greek in origin, from the word "phylax", meaning "to guard" and "watching."
Low Risk Patients
Young healthy people do not need prophylaxis against COVID-19. In young and healthy people, this infection causes mild cold-like symptoms. It is advantageous for these patients to be exposed to COVID-19, build up their antibodies and have their immune system clear the virus. This will facilitate the development of herd immunity and help prevent future COVID-19 pandemics. However, if these patients desire prophylaxis against COVID-19, then they should take the protocol noted below.
Moderate-Risk Patients
Patients from this category are healthy but have high potential viral-load exposure. This group includes medical personnel, caregivers of high-risk patients, people who use public transportation, first responders and other essential personnel who are crucial to the continued functioning of society. These patients should be encouraged to take prophylaxis against COVID-19 in accordance with the protocol noted below.
High-Risk Patients
Patients are considered high risk if they are over the age of 60, or if they are younger than 60 but they have comorbidities, that is, they have other health conditions that put them at risk. These patients have between a 5 to 10 percent mortality rate if they are infected with COVID-19. These patients should be strongly encouraged to take prophylaxis against COVID-19 in accordance with the protocol noted below.
